# Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study

> **NCT04788927** · — · NOT_YET_RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 400 (estimated)

## Conditions studied

- Paraganglioma
- Pheochromocytoma
- Genetic Predisposition to Disease
- Pathology
- Somatic Mutation
- Head and Neck Cancer
- Neuroendocrine Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04788927
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2024-04-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04788927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04788927, "Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04788927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
